CI 71105

RestrictedCAS 4424-06-016 regulations across 16 markets

CI 71105 is a cosmetic ingredient classified as Colorant. Also known as CAS 4424-06-0. It is regulated in 16 markets including UAE, Bahrain, Brazil.

Also Known As

CAS Number
4424-06-0

Market Overview — 29 Markets

European Union1
United Kingdom1
United States
California
Maryland
Washington
Canada
Brazil1
South Korea
Japan
Taiwan1
Australia
Singapore1
Malaysia1
Thailand1
Indonesia1
Vietnam1
Philippines1
UAE1
Saudi Arabia1
Qatar1
Oman1
Kuwait1
Bahrain1
Russia
Belarus
Kazakhstan
Armenia
Kyrgyzstan

Detailed Regulations

Europe2 regulations
European UnionRestrictedAnnex IV #97
Chemical name
Bisbenzimidazo[2,1-b:2',1'-i]benzo[lmn][3,8]phenanthroline-8,17-dione
CAS
4424-06-0
Product type
Not to be used in products applied on mucous membranes
Color Index
CI 71105

Source: EC 1223/2009 Annex IV

United KingdomRestrictedAnnex IV #97
Chemical name
Bisbenzimidazo[2,1-b:2',1'-i]benzo[lmn][3,8]phenanthroline-8,17-dione
Product type
Not to be used in products applied on mucous membranes
Color Index
71105

Source: UK retained EC 1223/2009 Annex IV

Americas1 regulation
BrazilRestrictedAnnex RDC_628 #CI_71105
Product type
not_mucous_membranes
Conditions of use
Application fields: not_mucous_membranes
Color Index
CI 71105

Source: ANVISA RDC 628

East Asia & Oceania1 regulation
TaiwanRestrictedAnnex Colorants List #95
Chemical name
CI 71105
Product type
Scope 3: Cosmetic products intended not to come into contact with the mucous membranes
Color Index
CI 71105

Source: TFDA Cosmetics Regulations

ASEAN6 regulations
SingaporeRestrictedAnnex ACD Annex IV (Colorants) #71105
Chemical name
Orange
Product type
All cosmetic products except those in contact with mucous membranes
Color Index
CI 71105

Source: ASEAN Cosmetic Directive (HSA Dec 2025)

MalaysiaRestrictedAnnex ACD Annex IV (Colorants) #71105
Chemical name
Orange
Product type
All cosmetic products except those in contact with mucous membranes
Color Index
CI 71105

Source: ASEAN Cosmetic Directive (HSA Dec 2025)

ThailandRestrictedAnnex ACD Annex IV (Colorants) #71105
Chemical name
Orange
Product type
All cosmetic products except those in contact with mucous membranes
Color Index
CI 71105

Source: ASEAN Cosmetic Directive (HSA Dec 2025)

IndonesiaRestrictedAnnex ACD Annex IV (Colorants) #71105
Chemical name
Orange
Product type
All cosmetic products except those in contact with mucous membranes
Color Index
CI 71105

Source: ASEAN Cosmetic Directive (HSA Dec 2025)

VietnamRestrictedAnnex ACD Annex IV (Colorants) #71105
Chemical name
Orange
Product type
All cosmetic products except those in contact with mucous membranes
Color Index
CI 71105

Source: ASEAN Cosmetic Directive (HSA Dec 2025)

PhilippinesRestrictedAnnex ACD Annex IV (Colorants) #71105
Chemical name
Orange
Product type
All cosmetic products except those in contact with mucous membranes
Color Index
CI 71105

Source: ASEAN Cosmetic Directive (HSA Dec 2025)

GCC6 regulations
UAERestrictedAnnex IV #97
Chemical name
Bisbenzimidazo[2,1-b:2',1'-i]benzo[lmn][3,8]phenanthroline-8,17-dione
CAS
4424-06-0
Product type
Not to be used in products applied on mucous membranes
Color Index
CI 71105

Source: GSO 1943:2024 (based on EU 1223/2009 IV)

Saudi ArabiaRestrictedAnnex IV #97
Chemical name
Bisbenzimidazo[2,1-b:2',1'-i]benzo[lmn][3,8]phenanthroline-8,17-dione
CAS
4424-06-0
Product type
Not to be used in products applied on mucous membranes
Color Index
CI 71105

Source: GSO 1943:2024 (based on EU 1223/2009 IV)

QatarRestrictedAnnex IV #97
Chemical name
Bisbenzimidazo[2,1-b:2',1'-i]benzo[lmn][3,8]phenanthroline-8,17-dione
CAS
4424-06-0
Product type
Not to be used in products applied on mucous membranes
Color Index
CI 71105

Source: GSO 1943:2024 (based on EU 1223/2009 IV)

OmanRestrictedAnnex IV #97
Chemical name
Bisbenzimidazo[2,1-b:2',1'-i]benzo[lmn][3,8]phenanthroline-8,17-dione
CAS
4424-06-0
Product type
Not to be used in products applied on mucous membranes
Color Index
CI 71105

Source: GSO 1943:2024 (based on EU 1223/2009 IV)

KuwaitRestrictedAnnex IV #97
Chemical name
Bisbenzimidazo[2,1-b:2',1'-i]benzo[lmn][3,8]phenanthroline-8,17-dione
CAS
4424-06-0
Product type
Not to be used in products applied on mucous membranes
Color Index
CI 71105

Source: GSO 1943:2024 (based on EU 1223/2009 IV)

BahrainRestrictedAnnex IV #97
Chemical name
Bisbenzimidazo[2,1-b:2',1'-i]benzo[lmn][3,8]phenanthroline-8,17-dione
CAS
4424-06-0
Product type
Not to be used in products applied on mucous membranes
Color Index
CI 71105

Source: GSO 1943:2024 (based on EU 1223/2009 IV)

EAEUNo restrictions

No specific restrictions for CI 71105 in Russia, Belarus, Kazakhstan, Armenia, Kyrgyzstan.

Frequently Asked Questions

Is CI 71105 banned in any country?

CI 71105 is not banned in any of the 26 markets tracked by Formpli. However, it may be subject to restrictions or conditions of use in some markets.

What are the restrictions on CI 71105 in cosmetics?

CI 71105 is restricted or has conditions of use in UAE, Bahrain, Brazil, European Union, Indonesia, Kuwait, Malaysia, Oman, Philippines, Qatar, Saudi Arabia, Singapore, Thailand, Taiwan, United Kingdom, Vietnam. Restrictions may include maximum concentration limits, product type limitations, or mandatory labeling requirements. See the detailed regulations above for specifics.

Can I use CI 71105 in cosmetics?

CI 71105 is regulated in 16 markets. It has restrictions in UAE, Bahrain, Brazil, European Union, Indonesia, Kuwait, Malaysia, Oman, Philippines, Qatar, Saudi Arabia, Singapore, Thailand, Taiwan, United Kingdom, Vietnam. Use Formpli's free screening tool to check your full ingredient list against all 26 markets at once.

Screen CI 71105 with your full formula

Paste your entire ingredient list and get a compliance report across 26 markets — free, no signup.

Check Ingredients Free

This information is for reference only and does not constitute legal or regulatory advice. Regulations change — always verify with official sources and consult a regulatory specialist before exporting cosmetic products. Data sourced from EU COSING, US FDA, Health Canada, MHLW Japan, MFDS Korea, ASEAN ACD, GCC SFDA, TGA Australia, ANVISA Brazil, EAEU TR CU, and Taiwan TFDA.